MSTX Thanks much Sheff for the headsup <link back>- just opened Schwab this morning to find:
8:08AM Mast Therapeutics Provides Additional Results From Nonclinical Heart Failure Study; Statistically significant and durable reductions in troponin and NT-proBNP (MSTX) 0.81 : Co announced new data from its randomized, placebo-controlled, nonclinical study of MST-188 (low dose and high dose) in a model of chronic heart failure. The Company previously announced that a single, two-hour infusion of MST-188 improved left ventricular systolic function that was significant immediately and remained significant at one week after MST-188 administration. In particular, MST-188 demonstrated a statistically significant improvement in left ventricular ejection fraction, end-systolic volume, stroke volume and cardiac output.
Watch your thoughts; they become words.
Watch your words; they become actions.
Watch your actions; they become habits.
Watch your habits; they become character.
Watch your character; it becomes your destiny.
